# Clover Health (CLOV) — Earnings

CLOV · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/clov/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q2 2026 |
| Period end | Jun 30, 2026 |
| EPS actual | $0.05 |
| EPS estimate | $0.04 |
| EPS surprise | +29.53% |
| Revenue surprise | +2.05% |
| Revenue | $743.2M |
| Revenue estimate | $728.3M |
| Reported | Aug 5, 2026 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1801170/000180117026000200/clov-20260630.htm) |
| Earnings call | [Transcript](http://o.thsi.cn/dc-d-stock-america.teleconference/672c625c-ee35-d3a8-e06e-106fb6b08cf2.html) |

Clover Health reported Q2 2026 results on August 5, 2026. Earnings per share were $0.05, ahead of the $0.04 estimate by 29.53%. Revenue of $743.2 million beat the $728.3 million consensus by 2.05%. A year earlier, in Q2 2025, Clover Health posted a loss of $0.02 per share, and revenue has since risen about 56% from $477.6 million.

The table shows losses narrowing into profit. Annual losses shrank from $0.72 per share in 2022 to $0.45 in 2023, $0.10 in 2024 and $0.07 in 2025. Revenue fell from $3.48 billion in 2022 to $1.37 billion in 2024, then recovered to $1.92 billion in 2025. The first half of 2026 brought revenue of $1.49 billion, up about 59% from a year earlier, and EPS of $0.12 against $0.03. Q1 2026 holds the EPS high at $0.07, and Q4 2022 the revenue high at $898.8 million. Clover Health beat the EPS estimate in 15 of the last 20 quarters.

Clover Health reported Q3 between November 4 and November 8 in each of the past five years. That points to early November 2026 for the next report. It will show whether Clover Health stays profitable for a third straight quarter.

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q2 2026 | Aug 5, 2026 | $0.04 | $0.05 | 29.53% | $728.3M | $743.2M |
| Q1 2026 | May 6, 2026 | $0.07 | $0.07 | 5.62% | $714.9M | $749.2M |
| Q4 2025 | Feb 26, 2026 | −$0.10 | −$0.05 | 50.44% | $492.7M | $487.7M |
| Q3 2025 | Nov 4, 2025 | −$0.03 | −$0.05 | -66.67% | $471.1M | $496.6M |
| Q2 2025 | Aug 5, 2025 | −$0.01 | −$0.02 | -117.39% | $468.3M | $477.6M |
| Q1 2025 | May 6, 2025 | −$0.04 | $0.05 | 230.81% | $466.9M | $462.3M |
| Q4 2024 | Feb 27, 2025 | −$0.07 | −$0.04 | 39.30% | $347.4M | $337.0M |
| Q3 2024 | Nov 6, 2024 | −$0.04 | −$0.02 | 51.10% | $346.3M | $331.0M |
| Q2 2024 | Aug 5, 2024 | −$0.05 | $0.01 | 120.62% | $338.8M | $356.3M |
| Q1 2024 | May 7, 2024 | −$0.07 | −$0.05 | 30.84% | $321.2M | $346.9M |
| Q4 2023 | Mar 12, 2024 | −$0.14 | −$0.15 | -4.95% | $474.0M | $510.3M |
| Q3 2023 | Nov 6, 2023 | −$0.11 | −$0.09 | 18.28% | $494.6M | $482.1M |
| Q2 2023 | Aug 8, 2023 | −$0.14 | −$0.06 | 56.67% | $490.8M | $513.6M |
| Q1 2023 | May 9, 2023 | −$0.17 | −$0.15 | 8.95% | $498.7M | $527.8M |
| Q4 2022 | Feb 28, 2023 | −$0.24 | −$0.18 | 26.52% | $785.5M | $898.8M |
| Q3 2022 | Nov 7, 2022 | −$0.22 | −$0.16 | 29.69% | $799.5M | $856.8M |
| Q2 2022 | Aug 8, 2022 | −$0.20 | −$0.22 | -11.37% | $814.6M | $846.7M |
| Q1 2022 | May 9, 2022 | −$0.27 | −$0.16 | 40.39% | $787.4M | $874.4M |
| Q4 2021 | Feb 23, 2022 | −$0.26 | −$0.34 | -31.53% | $408.1M | $432.0M |
| Q3 2021 | Nov 8, 2021 | −$0.23 | −$0.08 | 65.02% | $413.1M | $427.2M |

## Frequently Asked Questions

### When did Clover Health (CLOV) last report earnings?

Clover Health last reported on Aug 5, 2026, covering fiscal Q2 2026.

### Did CLOV beat earnings estimates?

Yes. Clover Health reported EPS of $0.05 for Q2 2026 against a $0.04 estimate — a 29.53% beat.

### How much revenue did CLOV report last quarter?

Clover Health reported $743.2M in revenue for Q2 2026, against a consensus estimate of $728.3M.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).